Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)

FRA:08HH Statistics

Total Valuation

FRA:08HH has a market cap or net worth of EUR 8.25 billion. The enterprise value is 12.63 billion.

Market Cap	8.25B
Enterprise Value	12.63B

Important Dates

The next estimated earnings date is Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	Jul 24, 2025

Share Statistics

Current Share Class	540.97M
Shares Outstanding	n/a
Shares Change (YoY)	-1.39%
Shares Change (QoQ)	-1.19%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	12.04%
Float	1.67B

Valuation Ratios

The trailing PE ratio is 21.00.

PE Ratio	21.00
Forward PE	n/a
PS Ratio	1.74
PB Ratio	1.13
P/TBV Ratio	3.00
P/FCF Ratio	215.23
P/OCF Ratio	14.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.61, with an EV/FCF ratio of 329.42.

EV / Earnings	32.15
EV / Sales	2.63
EV / EBITDA	19.61
EV / EBIT	42.27
EV / FCF	329.42

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.60.

Current Ratio	0.92
Quick Ratio	0.66
Debt / Equity	0.60
Debt / EBITDA	6.93
Debt / FCF	114.65
Interest Coverage	1.84

Financial Efficiency

Return on equity (ROE) is 6.75% and return on invested capital (ROIC) is 1.60%.

Return on Equity (ROE)	6.75%
Return on Assets (ROA)	1.32%
Return on Invested Capital (ROIC)	1.60%
Return on Capital Employed (ROCE)	2.96%
Revenue Per Employee	116,742
Profits Per Employee	9,690
Employee Count	40,557
Asset Turnover	0.34
Inventory Turnover	2.91

Taxes

In the past 12 months, FRA:08HH has paid 105.96 million in taxes.

Income Tax	105.96M
Effective Tax Rate	17.93%

Stock Price Statistics

The stock price has increased by +33.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+33.87%
50-Day Moving Average	2.58
200-Day Moving Average	2.09
Relative Strength Index (RSI)	33.38
Average Volume (20 Days)	588

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:08HH had revenue of EUR 4.73 billion and earned 392.98 million in profits. Earnings per share was 0.15.

Revenue	4.73B
Gross Profit	2.25B
Operating Income	294.12M
Pretax Income	590.82M
Net Income	392.98M
EBITDA	583.97M
EBIT	294.12M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 1.62 billion in cash and 4.40 billion in debt, giving a net cash position of -2.78 billion.

Cash & Cash Equivalents	1.62B
Total Debt	4.40B
Net Cash	-2.78B
Net Cash Per Share	n/a
Equity (Book Value)	7.28B
Book Value Per Share	2.18
Working Capital	-352.15M

Cash Flow

In the last 12 months, operating cash flow was 583.28 million and capital expenditures -544.93 million, giving a free cash flow of 38.35 million.

Operating Cash Flow	583.28M
Capital Expenditures	-544.93M
Free Cash Flow	38.35M
FCF Per Share	n/a

Margins

Gross margin is 47.50%, with operating and profit margins of 6.21% and 8.30%.

Gross Margin	47.50%
Operating Margin	6.21%
Pretax Margin	12.48%
Profit Margin	8.30%
EBITDA Margin	12.33%
EBIT Margin	6.21%
FCF Margin	0.81%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.64%.

Dividend Per Share	0.04
Dividend Yield	1.64%
Dividend Growth (YoY)	7.35%
Years of Dividend Growth	n/a
Payout Ratio	63.02%
Buyback Yield	1.39%
Shareholder Yield	3.03%
Earnings Yield	4.76%
FCF Yield	0.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:08HH has an Altman Z-Score of 1.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.4
Piotroski F-Score	4